Live Coronavirus, last minute
While the
European Union
continues to make a mess (to put it mildly) with vaccines, the
United States
seems to be making rapid progress in their distribution, to the point that by the end of July it could achieve the much-desired 'group immunity', which occurs when 70% and 90% of the population of a country is immunized.
This was stated this Thursday by US President
Joe Biden
during a visit to the
National Institutes of Health (NIH
), in
Bethesda (Maryland),
outside of
Washington.
Biden confirmed that the US is
going to purchase 200 million doses
- half from
Pfizer and BioNTech
and the other half from
Moderna
-
bringing the country's stock of doses to
600 million.
That means that, in theory at least, the US will have the
capacity to vaccinate 300 million people,
exactly 91% of the population.
In fact, there are
255 million adults in the US.
Since minors are not going to be vaccinated, Biden's numbers show that the country is, in fact, going to have more vaccinations than necessary.
Biden has repeatedly stated that he prefers the US to have a stock of vaccines.
And he has accused former President
Donald Trump
of buying an insufficient number of drugs.
"My predecessor, to be clear,
didn't do his job,"
Biden said on his visit to the NIH.
Obviously, it is one thing to have the vaccines and another to distribute them.
But the US president is confident that the deadlines will accelerate.
During his visit, he announced that the deliveries scheduled for the end of June have been advanced to the end of May.
These figures also do not include the
Johnson & Johnson
vaccine
,
whose use could be approved this week or next week and which has the advantage that it only needs one dose, unlike those of Pfizer-BioNTech and Moderna, nor the of
Novavax,
which could be approved in March.
The
efficacy of all these drugs against
British
mutations
, and especially Brazilian and South African
mutations
, is lower than against those that have been dominant up to now, but, even so, it is high enough to guarantee their efficacy, according to experts. It is not clear, however, that this is the case with the vaccine developed by the British company
AstraZeneca
and the
University of Oxford,
which is the one that the EU and
Great Britain
have focused on
.
According to the criteria of The Trust Project
Know more
Coronavirus
Covid 19
U.S
Joe biden
Donald trump
Vaccines
CoronavirusJoe Biden announces that passengers traveling to the US must quarantine upon arrival
Covid-19 Yankee Stadium, a mass vaccination center in the Latin Quarter of New York
Diplomacy & GeopoliticsTurbulence and a zasca on the route of Spanish diplomacy
See links of interest
Work calendar
Rafa Nadal - Michael Mmoh, live
Tenerife-San Pablo Burgos
Bayern Munich - Tigers
Athletic Club - Levante
Real Madrid-Valencia Basket